68Ga-FAPI PET/CT在评估肝胆恶性肿瘤中的作用:一项前瞻性先导研究
前瞻性纳入疑似肝细胞癌和胆管癌患者41例,在1周内完成FDG与FAPI PET/CT,以组织诊断和常规影像为最终诊断。FAPI PET/CT诊断原发肝胆恶性肿瘤的灵敏度、特异度和准确度分别为96.77%、90%和95.12%,FDG PET/CT分别为51.61%、100%和63.41%;FAPI在胆管癌评估中明显优于FDG,但在转移性肝细胞癌中诊断准确度为61.54%,低于FDG的84.62%。
要点
- FAPI PET/CT诊断原发肝胆恶性肿瘤灵敏度96.77%、特异度90%、准确度95.12%,均优于FDG PET/CT的51.61%、100%、63.41%。
- FAPI PET/CT评估胆管癌灵敏度94.4%、特异度100%、准确度95.24%,FDG PET/CT分别为50%、100%、57.14%。
- 转移性肝细胞癌中FAPI PET/CT诊断准确度为61.54%,低于FDG PET/CT的84.62%。
核心结论
- 本研究提示FAPI-PET/CT在评估胆管癌方面具有潜在作用,并确认其在黏液腺癌病例中的实用性。
- FAPI在原发性肝细胞癌中病灶检出率高于FDG,但其在转移性病变中的诊断性能存疑。
研究设计与样本
- 前瞻性先导研究,纳入疑似肝细胞癌和胆管癌患者,FDG与FAPI PET/CT检查在1周内完成。
- 最终恶性诊断通过组织诊断(组织病理学检查或细针穿刺细胞学)及常规影像学关联确定。
- 共纳入41例患者,31例恶性阳性、10例阴性,其中15例为转移性;31例恶性中18例为胆管癌、6例为肝细胞癌。
主要发现
- 原发疾病总体诊断:FAPI PET/CT灵敏度96.77%、特异度90%、准确度95.12%,FDG PET/CT分别为51.61%、100%、63.41%。
- 胆管癌评估:FAPI PET/CT灵敏度94.4%、特异度100%、准确度95.24%,FDG PET/CT分别为50%、100%、57.14%。
- 转移性肝细胞癌诊断准确度:FAPI PET/CT为61.54%,FDG PET/CT为84.62%。
关键数值与推荐
- 原发肝胆恶性肿瘤总体诊断FAPI PET/CT灵敏度96.77%、特异度90%、准确度95.12%。
- 胆管癌FAPI PET/CT灵敏度94.4%、特异度100%、准确度95.24%。
- 转移性肝细胞癌FAPI PET/CT诊断准确度61.54%,FDG PET/CT为84.62%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION AND AIM: Preliminary studies showed good expression of fibroblast activating protein inhibitor (FAPI) in hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). Our aims were to study the diagnostic performance of 68 Ga-FAPI PET/CT in diagnosing the primary hepatobiliary malignancies and to compare its performance with 18 F-FDG PET/CT. PATIENTS AND METHODS: Patients suspected to have HCC and CC were recruited prospectively. FDG and FAPI PET/CT studies were completed within 1 week. Final diagnosis of malignancy was achieved by tissue diagnosis (either histopathological examination or fine-needle aspiration cytology) and radiological correlation from conventional modalities. Results were compared with final diagnosis and expressed as sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy. RESULTS: Forty-one patients were included. Thirty-one were positive for malignancy and 10 were negative. Fifteen were metastatic. Of 31, 18 were CC and 6 were HCC. For overall diagnosis of the primary disease, FAPI PET/CT performed exceptionally compared with FDG PET/CT with sensitivity, specificity, and accuracy of 96.77%, 90%, and 95.12%, respectively, versus 51.61%, 100%, and 63.41% for FDG PET/CT. FAPI PET/CT clearly outperformed FDG PET/CT for the evaluation of CC with sensitivity, specificity, and accuracy of 94.4%, 100%, and 95.24%, respectively, whereas for FDG PET/CT sensitivity, specificity, and accuracy were 50%, 100%, and 57.14%, respectively. Diagnostic accuracy of FAPI PET/CT was 61.54% for metastatic HCC compared with 84.62% for FDG PET/CT. CONCLUSIONS: Our study highlights the potential role of FAPI-PET/CT in evaluating CC. It also ascertains its usefulness in the cases of mucinous adenocarcinoma. Although it showed a higher lesion detection rate than FDG in primary HCC, its diagnostic performance in the metastatic setting is questionable.
引用
- Rajaraman V, Meenakshi LA, Selvaraj AJ, et al. Role of 68 Ga-FAPI PET/CT in Assessing Hepatobiliary Malignancies : A Prospective Pilot Study. Clin Nucl Med. 2023. PMID: 37019124. doi:10.1097/RLU.0000000000004641
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。